News | Page 4
Daily news and information for physicians in a range of specialties and practice settings.
CD34+ Cell Therapy Receives Regenerative Medicine Advanced Therapy Designation by FDA for Refractory Angina
Clinical data demonstrate that CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina.
FDA Approves Phase 2 Trial of Lanifibranor in Patients with Diabetes, NAFLD
The first patient is anticipated to be enrolled in the third quarter of 2018, and topline results will be expected by the beginning of 2020.
WHO Adds Gaming Disorder to Internal Classification of Diseases
The condition is characterized by a display of persistent or recurrent gaming behavior, online or offline, and can appear in continuous, episodic, and recurrent patterns.
ACX-362E Antibiotic for C. Difficile Granted FDA QIDP Designation
The Qualified Infections Disease Product (QIDP) designation gives ACX-362E access to incentives including Priority Review and eligibility for Fast track status.
FDA Clears Kyphon HV-R Bone Cement Solution for Sacral Fractures
This minimally invasive procedure provides additional options for the patient population suffering with sacral insufficiency fractures.
Physician Resolve On Display as the Immigration Conversation Continues
New immigration policies are affecting the health of thousands of migrant children, and physicians want the world to know about it.
Atul Gawande Named CEO in Amazon, Berkshire Hathaway, JP Morgan Chase Joint Healthcare Initiative
The triad of companies said that, while the details have yet to be hammered out, the initiative will be long-term and “free from profit-making incentives and constraints.”
Focusing on Performance Improvement Methodology in Primary Care
The medical group’s primary care offices managed to reduce wasted patient minutes by 7.6% through efforts to streamline and shore up patient throughput.
Inappropriate Antimicrobial Prescriptions Linked to Recurrent Clostridium difficile
Many antimicrobials prescribed after
infection are prescribed inappropriately.
Interactive Therapy Reduces Childhood Depression
An interactive parent-child therapy appears to reduce depression in children 3-6 years old. Interestingly, the therapy also improved symptoms of clinical depression in participating parents.
<< Prev Page
Next Page >>
Insulin Degludec Injection Improves A1C, Hypoglycemic Episodes in CONFIRM
Robert Gabbay, MD, PhD: The Role of Patient-Provider Communication in Medication Adherence
New Botulinum Neurotoxin Controls Cervical Dystonia
Canagliflozin Continues Showing of Positive Renal Outcomes in CANVAS Data
The Embrace of Overseas Medical Schools
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.